Morgan Stanley Discount Zert SQ 3.../ DE000MG48H13 /
2024-05-31 8:46:55 PM | Chg.-0.24 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
32.58EUR | -0.73% | - Bid Size: - |
- Ask Size: - |
Block Inc | - USD | 2025-12-30 | Call |
GlobeNewswire
7:48 AM
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
GlobeNewswire
7:30 AM
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire
7:30 AM
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...
GlobeNewswire
6:00 AM
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire
5:01 AM
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
GlobeNewswire
5:00 AM
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire
4:59 AM
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
2:38 AM
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
2:00 AM
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire
1:00 AM
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
12:43 AM
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
06-02
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
06-02
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...